TriVascular, Inc
Has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR).
Launch date
Employees
Market cap
-
Enterprise valuation
$211m (Public information from Oct 2015)
Santa Rosa California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$65.0m | Series A | ||
$30.0m | Series B | ||
$60.0m | Series C | ||
* | N/A | $50.0m | Debt |
$60.0m | Series D | ||
N/A | $96.0m | Debt | |
N/A | $2.0m | Early VC | |
N/A | N/A | IPO | |
N/A | $10.0m | Post IPO Debt | |
$211m Valuation: $211m | Acquisition | ||
Total Funding | $217m |
Recent News about TriVascular, Inc
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.